PL2414333T3 - Reagenty i sposoby radioznakowania - Google Patents

Reagenty i sposoby radioznakowania

Info

Publication number
PL2414333T3
PL2414333T3 PL10710143T PL10710143T PL2414333T3 PL 2414333 T3 PL2414333 T3 PL 2414333T3 PL 10710143 T PL10710143 T PL 10710143T PL 10710143 T PL10710143 T PL 10710143T PL 2414333 T3 PL2414333 T3 PL 2414333T3
Authority
PL
Poland
Prior art keywords
radiolabelling
reagents
methods
radiolabelling reagents
Prior art date
Application number
PL10710143T
Other languages
English (en)
Inventor
Dag Erland Olberg
Joseph Maduabuchi Arukwe
Original Assignee
Ge Healthcare Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Uk Ltd filed Critical Ge Healthcare Uk Ltd
Publication of PL2414333T3 publication Critical patent/PL2414333T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL10710143T 2009-03-30 2010-03-22 Reagenty i sposoby radioznakowania PL2414333T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16449409P 2009-03-30 2009-03-30
GBGB0905438.8A GB0905438D0 (en) 2009-03-30 2009-03-30 Radiolabelling reagents and methods
PCT/US2010/028078 WO2010114723A1 (en) 2009-03-30 2010-03-22 Radiolabelling reagents and methods
EP10710143A EP2414333B1 (en) 2009-03-30 2010-03-22 Radiolabelling reagents and methods

Publications (1)

Publication Number Publication Date
PL2414333T3 true PL2414333T3 (pl) 2013-07-31

Family

ID=40671939

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10710143T PL2414333T3 (pl) 2009-03-30 2010-03-22 Reagenty i sposoby radioznakowania

Country Status (15)

Country Link
US (1) US8530620B2 (pl)
EP (1) EP2414333B1 (pl)
JP (1) JP2012522052A (pl)
KR (1) KR20110133038A (pl)
CN (2) CN102356069B (pl)
AU (1) AU2010232828A1 (pl)
BR (1) BRPI1011531A2 (pl)
CA (1) CA2757016A1 (pl)
ES (1) ES2404346T3 (pl)
GB (1) GB0905438D0 (pl)
MX (1) MX2011010295A (pl)
PL (1) PL2414333T3 (pl)
PT (1) PT2414333E (pl)
RU (1) RU2524284C2 (pl)
WO (1) WO2010114723A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2318366T (pt) 2008-08-01 2017-08-02 Univ Johns Hopkins Agentes de ligação a psma e suas utilizações
CN107753962A (zh) * 2010-12-09 2018-03-06 通用电气健康护理有限公司 放射性示踪剂组合物
WO2013048811A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Imaging and radiotherapy methods for tumour stem cells
TW201605852A (zh) * 2013-09-26 2016-02-16 美國禮來大藥廠 新穎化合物及其製備ｔａｕ造影劑及ｔａｕ造影調配物之用途
EP3183236B1 (en) * 2014-08-24 2022-04-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften Method for the production of 18f-labeled active esters and their application exemplified by the preparation of a psma-specific pet-tracer
KR102233726B1 (ko) 2015-09-30 2021-03-31 도이체스 크렙스포르슝스첸트룸 전립선 특이적 막 항원（psma)의 18f-태그된 저해제 및 전립선암에 대한 조영제로서 이의 용도
GB201518918D0 (en) 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method
WO2018022603A1 (en) * 2016-07-25 2018-02-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof
US11628229B2 (en) 2017-03-13 2023-04-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of synthesizing 18F radiolabeled biomolecular agents
GB202019006D0 (en) * 2020-12-02 2021-01-13 Vestlandets Innovasjonsselskap As GFR targeting compounds

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242680A (en) * 1991-08-23 1993-09-07 Merck & Co., Inc. Thiol-reactive maleimido-based radiolabeling reagents
US5346686A (en) * 1992-10-05 1994-09-13 Mallinckrodt Medical, Inc. Labelled interleukin-8 and medical uses thereof
DE69700902T2 (de) * 1996-01-23 2000-07-20 Rapigene, Inc. Verfahren zur erkennung von ligandenpaar bindung mit erhöter empfindlichkeit
DK0932417T3 (da) * 1996-10-17 2003-04-14 Immunomedics Inc Non-antigent toxinkonjugat og fusionsprotein af internaliserende receptorsystem
US6187284B1 (en) * 1997-09-03 2001-02-13 Immunomedics, Inc. Fluorination of proteins and peptides for F-18 positron emission tomography
US6350360B1 (en) 2000-04-07 2002-02-26 Sandia Coroporation Method of fabricating a 3-dimensional tool master
GB0115927D0 (en) * 2001-06-29 2001-08-22 Nycomed Amersham Plc Solid-phase nucleophilic fluorination
BRPI0210886B8 (pt) 2001-07-10 2021-05-25 Amersham Health As composto, composição farmacêutica, uso de um composto, e, métodos de geração de imagens, de monitoração do efeito do tratamento de um corpo humano ou animal com uma droga para combater uma condição associada com câncer e de tratamento de câncer ou de uma doença relacionada em um corpo humano ou animal
FR2841554B1 (fr) * 2002-07-01 2008-01-18 Commissariat Energie Atomique Composes de maleimides marques, leur procede de preparation et leur utilisation pour le marquage de macromolecules
GB0305704D0 (en) 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) 2003-07-30 2003-09-03 Amersham Health As Imaging agents
GB0329716D0 (en) 2003-12-23 2004-01-28 Amersham Plc Radical trap
GB0420344D0 (en) * 2004-09-14 2004-10-13 Amersham Plc Diagnostic compounds
KR20100022987A (ko) * 2007-06-20 2010-03-03 지이 헬쓰케어 리미티드 표지 방법
WO2009035959A2 (en) * 2007-09-10 2009-03-19 Ge Healthcare Limited Radiofluorination methods
FR2926079B1 (fr) * 2008-01-03 2012-12-28 Commissariat Energie Atomique Procede de preparation d'un derive de purine marque, ledit derive et ses utilisations

Also Published As

Publication number Publication date
PT2414333E (pt) 2013-05-07
ES2404346T3 (es) 2013-05-27
GB0905438D0 (en) 2009-05-13
CN102356069A (zh) 2012-02-15
MX2011010295A (es) 2012-03-26
US8530620B2 (en) 2013-09-10
EP2414333B1 (en) 2013-02-13
US20120022227A1 (en) 2012-01-26
AU2010232828A1 (en) 2011-10-13
CN104292155A (zh) 2015-01-21
JP2012522052A (ja) 2012-09-20
RU2524284C2 (ru) 2014-07-27
KR20110133038A (ko) 2011-12-09
RU2011139219A (ru) 2013-05-10
EP2414333A1 (en) 2012-02-08
BRPI1011531A2 (pt) 2016-03-29
WO2010114723A1 (en) 2010-10-07
CA2757016A1 (en) 2010-10-07
CN102356069B (zh) 2014-09-24

Similar Documents

Publication Publication Date Title
IL250624A0 (en) Anti-fgfr3 antibodies and methods of using them
IL244197A0 (en) Antibodies against cd100 and methods of using them
EP2494062A4 (en) ANTI-GLP-1R ANTIBODIES AND THEIR USES
ZA201107486B (en) Anti-tnf-x antibodies and their uses
SG10201402628VA (en) Specific Diarylhydantoin And Diarylthiohydantoin Compounds
IL209309A0 (en) Anti-fn14 antibodies and uses thereof
GB0905519D0 (en) Assay method and device
IL216731A (en) And antibodies against p95 – her2 and their uses
PL2414333T3 (pl) Reagenty i sposoby radioznakowania
SG10201609416XA (en) NOVEL ANTI-α5ß1 ANTIBODIES AND USES THEREOF
DK2510317T3 (en) Flowmeter and method
IL220536A0 (en) Anti - bv8 antibodies and uses thereof
GB0914826D0 (en) Assay methods
PL2373675T3 (pl) Reagenty funkcjonalizujące tiole oraz ich zastosowania
GB0902316D0 (en) Pathogen detector assay, method and kit
GB2476235B (en) Microfluidics apparatus and methods
GB0903151D0 (en) Antibody uses and methods
IL219136A0 (en) Anti-hepsin antibodies and methods using same
IL214527A0 (en) Anti-mst1r antibodies and uses thereof
GB0912744D0 (en) Methods and uses
GB0905515D0 (en) Radiolabelling methods
EP2470022A4 (en) COMPOUNDS AND METHODS
GB0903348D0 (en) Compounds and methods relating thereto
GB0822140D0 (en) Methods and reagents
GB0906115D0 (en) Antibody and uses thereof